British HIV Association opportunistic infection guidelines: in defence of amphotericin B deoxycholate.
T
T
Bicanic
D
D
Ogden
L
L
Whitney
A
A
Loyse
J
J
Jarvis
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000503:physiopathology; D000666:Amphotericin B / Q000008:administration & dosage / Q000494:pharmacology*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000494:pharmacology*; D003840:Deoxycholic Acid / Q000008:administration & dosage / Q000494:pharmacology*; D004334:Drug Administration Schedule; D004338:Drug Combinations; D005260:Female; D017408:Guidelines as Topic; D006679:HIV Seropositivity / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008297:Male; D016919:Meningitis, Cryptococcal / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology
D000935:Antifungal Agents; D004338:Drug Combinations; D003840:Deoxycholic Acid; D000666:Amphotericin B; C059765:amphotericin B, deoxycholate drug combination